Penserra Capital Management LLC Reata Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$25.61 - $110.96 $18,439 - $79,891
-720 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$100.0 - $143.02 $500 - $715
5 Added 0.7%
720 $72,000
Q2 2021

Aug 12, 2021
BUY
$78.27 - $151.29 $1,174 - $2,269
15 Added 2.14%
715 $101,000
Q1 2021

May 13, 2021
BUY
$94.25 - $132.81 $3,298 - $4,648
35 Added 5.26%
700 $69,000
Q4 2020

Feb 12, 2021
BUY
$102.03 - $184.62 $67,849 - $122,772
665 New
665 $82,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email